Ionis Pharmaceuticals (IONS) Current Assets (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Current Assets of $2.5 billion for Q2 2026, down 3.33% year-over-year from $2.6 billion in Q2 2025, and down 15.17% quarter-over-quarter from $2.9 billion in Q1 2026.
Ionis Pharmaceuticals (IONS) Current Assets (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Current Assets history runs 18 years deep, the most recent figure standing at $2.5 billion for Q2 2026.
- In Q2 2026, Current Assets fell 3.33% year-over-year to $2.5 billion; the TTM figure through Jun 2026 stood at $2.5 billion (down 3.33% YoY), while the FY2025 annual figure was $3.0 billion, up 14.13% from the prior year.
- Current Assets for Q2 2026 stood at $2.5 billion, down from $2.9 billion in the prior quarter.
- The five-year high for Current Assets was $3.0 billion in Q4 2025, with the low at $2.2 billion in Q3 2022.
- The 5-year median for Current Assets is $2.5 billion (2023), against an average of $2.5 billion.
- The sharpest annual moves came in 2024 and 2026: Current Assets retreated 10.98% in 2024, then grew 21.41% in 2026.
- Ionis Pharmaceuticals' Current Assets stood at $2.2 billion in 2022, then advanced by 19.94% to $2.6 billion in 2023, then decreased by 0.82% to $2.6 billion in 2024, then gained by 14.13% to $3.0 billion in 2025, then decreased by 16.7% to $2.5 billion in 2026.
- Business Quant data shows IONS's Current Assets at $2.5 billion in Q2 2026, $2.9 billion in Q1 2026, and $3.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 2.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Bn |
| Mar 31, 2026 | 2.94 Bn |
| Dec 31, 2025 | 2.99 Bn |
| Sep 30, 2025 | 2.52 Bn |
| Jun 30, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.42 Bn |
| Dec 31, 2024 | 2.62 Bn |
| Sep 30, 2024 | 2.71 Bn |
| Jun 30, 2024 | 2.33 Bn |
| Mar 31, 2024 | 2.42 Bn |
| Dec 31, 2023 | 2.64 Bn |
| Sep 30, 2023 | 2.58 Bn |
| Jun 30, 2023 | 2.62 Bn |
| Mar 31, 2023 | 2.54 Bn |
| Dec 31, 2022 | 2.20 Bn |
| Sep 30, 2022 | 2.15 Bn |
| Jun 30, 2022 | 2.19 Bn |
| Mar 31, 2022 | 2.25 Bn |
| Dec 31, 2021 | 2.35 Bn |
| Sep 30, 2021 | 2.16 Bn |